Found 109 hits with Last Name = 'clare' and Initial = 'pm' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133557
(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-morphol...)Show InChI InChI=1S/C15H16Cl2N4O2S/c16-11-2-1-3-12(17)10(11)8-14-18-13(9-24-14)19-15(22)20-21-4-6-23-7-5-21/h1-3,9H,4-8H2,(H2,19,20,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| 500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Inhibition of Tau Protein Kinase II (TPK II) |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7163
(3-Phenylacetamidoaminopyrazole deriv. 40 | CS10 | ...)Show InChI InChI=1S/C18H17N3OS/c22-18(19-17-11-15(20-21-17)13-7-8-13)10-12-3-5-14(6-4-12)16-2-1-9-23-16/h1-6,9,11,13H,7-8,10H2,(H2,19,20,21,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| MMDB PC cid PC sid PDB UniChem
| Article PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7162
(3-Phenylacetamidoaminopyrazole deriv. 39 | 4 -{2-[...)Show SMILES NC(=O)c1ccc(cc1)-c1ccc(CC(=O)Nc2cc(n[nH]2)C2CC2)cc1 Show InChI InChI=1S/C21H20N4O2/c22-21(27)17-9-5-15(6-10-17)14-3-1-13(2-4-14)11-20(26)23-19-12-18(24-25-19)16-7-8-16/h1-6,9-10,12,16H,7-8,11H2,(H2,22,27)(H2,23,24,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7159
(3-Phenylacetamidoaminopyrazole deriv. 36 | N-(5-Cy...)Show SMILES Fc1cccc(c1)-c1ccc(CC(=O)Nc2cc(n[nH]2)C2CC2)cc1 Show InChI InChI=1S/C20H18FN3O/c21-17-3-1-2-16(11-17)14-6-4-13(5-7-14)10-20(25)22-19-12-18(23-24-19)15-8-9-15/h1-7,11-12,15H,8-10H2,(H2,22,23,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7160
(3-Phenylacetamidoaminopyrazole deriv. 37 | N-(5-Cy...)Show SMILES Cc1cccc(c1)-c1ccc(CC(=O)Nc2cc(n[nH]2)C2CC2)cc1 Show InChI InChI=1S/C21H21N3O/c1-14-3-2-4-18(11-14)16-7-5-15(6-8-16)12-21(25)22-20-13-19(23-24-20)17-9-10-17/h2-8,11,13,17H,9-10,12H2,1H3,(H2,22,23,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7161
(3-Phenylacetamidoaminopyrazole deriv. 38 | 4 -{2-[...)Show SMILES OC(=O)c1ccc(cc1)-c1ccc(CC(=O)Nc2cc(n[nH]2)C2CC2)cc1 Show InChI InChI=1S/C21H19N3O3/c25-20(22-19-12-18(23-24-19)16-7-8-16)11-13-1-3-14(4-2-13)15-5-9-17(10-6-15)21(26)27/h1-6,9-10,12,16H,7-8,11H2,(H,26,27)(H2,22,23,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7121
(3-Aminopyrazole deriv. 36 | N-(5-Cyclopropyl-1H-py...)Show SMILES CC(C(=O)Nc1cc(n[nH]1)C1CC1)c1ccc(cc1)N1CCCS1(=O)=O Show InChI InChI=1S/C18H22N4O3S/c1-12(18(23)19-17-11-16(20-21-17)14-3-4-14)13-5-7-15(8-6-13)22-9-2-10-26(22,24)25/h5-8,11-12,14H,2-4,9-10H2,1H3,(H2,19,20,21,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7155
(3-Phenylacetamidoaminopyrazole deriv. 32 | CHEMBL1...)Show InChI InChI=1S/C15H17N3O2/c1-20-12-4-2-3-10(7-12)8-15(19)16-14-9-13(17-18-14)11-5-6-11/h2-4,7,9,11H,5-6,8H2,1H3,(H2,16,17,18,19) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7128
(3-Benzamidoaminopyrazole deriv. 5 | 4-bromo-N-(5-c...)Show InChI InChI=1S/C13H12BrN3O/c14-10-5-3-9(4-6-10)13(18)15-12-7-11(16-17-12)8-1-2-8/h3-8H,1-2H2,(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7165
(3-Phenylacetamidoaminopyrazole deriv. 42 | N-(5-Cy...)Show InChI InChI=1S/C18H17N3O/c22-18(19-17-11-16(20-21-17)13-8-9-13)10-14-6-3-5-12-4-1-2-7-15(12)14/h1-7,11,13H,8-10H2,(H2,19,20,21,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7153
(3-Phenylacetamidoaminopyrazole deriv. 30 | CHEMBL1...)Show InChI InChI=1S/C14H15N3O/c18-14(8-10-4-2-1-3-5-10)15-13-9-12(16-17-13)11-6-7-11/h1-5,9,11H,6-8H2,(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7143
(3-Benzamidoaminopyrazole deriv. 20 | 4-bromo-N-(5-...)Show InChI InChI=1S/C15H16BrN3O/c16-12-7-5-11(6-8-12)15(20)17-14-9-13(18-19-14)10-3-1-2-4-10/h5-10H,1-4H2,(H2,17,18,19,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7158
(2-(1,1 -Biphenyl-4-yl)-N-(5-cyclopropyl-1H-pyrazol...)Show SMILES O=C(Cc1ccc(cc1)-c1ccccc1)Nc1cc(n[nH]1)C1CC1 Show InChI InChI=1S/C20H19N3O/c24-20(21-19-13-18(22-23-19)17-10-11-17)12-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,13,17H,10-12H2,(H2,21,22,23,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 56 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7157
(3-Phenylacetamidoaminopyrazole deriv. 34 | CHEMBL1...)Show SMILES FC(F)(F)Oc1ccc(CC(=O)Nc2cc(n[nH]2)C2CC2)cc1 Show InChI InChI=1S/C15H14F3N3O2/c16-15(17,18)23-11-5-1-9(2-6-11)7-14(22)19-13-8-12(20-21-13)10-3-4-10/h1-2,5-6,8,10H,3-4,7H2,(H2,19,20,21,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MMDB PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7132
(1-N-(5-cyclopropyl-1H-pyrazol-3-yl)benzene-1,4-dic...)Show InChI InChI=1S/C14H14N4O2/c15-13(19)9-3-5-10(6-4-9)14(20)16-12-7-11(17-18-12)8-1-2-8/h3-8H,1-2H2,(H2,15,19)(H2,16,17,18,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 68 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7154
(3-Phenylacetamidoaminopyrazole deriv. 31 | 4-{2-[(...)Show InChI InChI=1S/C15H16N4O2/c16-15(21)11-3-1-9(2-4-11)7-14(20)17-13-8-12(18-19-13)10-5-6-10/h1-4,8,10H,5-7H2,(H2,16,21)(H2,17,18,19,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7123
((2S)-N-(5-Cyclopropyl-1H-pyrazol-3-yl)-2-(4-pyrrol...)Show SMILES C[C@H](C(=O)Nc1cc(n[nH]1)C1CC1)c1ccc(cc1)N1CCCC1 |r| Show InChI InChI=1S/C19H24N4O/c1-13(14-6-8-16(9-7-14)23-10-2-3-11-23)19(24)20-18-12-17(21-22-18)15-4-5-15/h6-9,12-13,15H,2-5,10-11H2,1H3,(H2,20,21,22,24)/t13-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 80 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7141
(3,4-dichloro-N-(5-cyclopropyl-1H-pyrazol-3-yl)benz...)Show InChI InChI=1S/C13H11Cl2N3O/c14-9-4-3-8(5-10(9)15)13(19)16-12-6-11(17-18-12)7-1-2-7/h3-7H,1-2H2,(H2,16,17,18,19) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 83 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7129
(3-Benzamidoaminopyrazole deriv. 6 | 4-chloro-N-(5-...)Show InChI InChI=1S/C13H12ClN3O/c14-10-5-3-9(4-6-10)13(18)15-12-7-11(16-17-12)8-1-2-8/h3-8H,1-2H2,(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 85 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7142
(3-Benzamidoaminopyrazole deriv. 19 | 4-bromo-N-(5-...)Show InChI InChI=1S/C14H14BrN3O/c15-11-6-4-10(5-7-11)14(19)16-13-8-12(17-18-13)9-2-1-3-9/h4-9H,1-3H2,(H2,16,17,18,19) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-dependent kinase 2/G1/S-specific cyclin-E1
(Homo sapiens (Human)) | BDBM7108
((N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(2-naphthyl)a...)Show InChI InChI=1S/C18H17N3O/c22-18(19-17-11-16(20-21-17)14-7-8-14)10-12-5-6-13-3-1-2-4-15(13)9-12/h1-6,9,11,14H,7-8,10H2,(H2,19,20,21,22) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| DrugBank MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 92 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7156
(3-Phenylacetamidoaminopyrazole deriv. 33 | N-(5-Cy...)Show SMILES O=C(Cc1ccc(OCCN2CCCC2)cc1)Nc1cc(n[nH]1)C1CC1 Show InChI InChI=1S/C20H26N4O2/c25-20(21-19-14-18(22-23-19)16-5-6-16)13-15-3-7-17(8-4-15)26-12-11-24-9-1-2-10-24/h3-4,7-8,14,16H,1-2,5-6,9-13H2,(H2,21,22,23,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| MMDB PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 95 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1 [99-307]
(Homo sapiens (Human)) | BDBM7108
((N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(2-naphthyl)a...)Show InChI InChI=1S/C18H17N3O/c22-18(19-17-11-16(20-21-17)14-7-8-14)10-12-5-6-13-3-1-2-4-15(13)9-12/h1-6,9,11,14H,7-8,10H2,(H2,19,20,21,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| DrugBank MMDB PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 114 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7131
(3-Benzamidoaminopyrazole deriv. 8 | 4-[(5-cyclopro...)Show InChI InChI=1S/C14H13N3O3/c18-13(9-3-5-10(6-4-9)14(19)20)15-12-7-11(16-17-12)8-1-2-8/h3-8H,1-2H2,(H,19,20)(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 165 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7122
(3-Aminopyrazole deriv. 37 | N-(5-Cyclopropyl-1H-py...)Show SMILES CC(C(=O)Nc1cc(n[nH]1)C1CC1)c1ccc(cc1)N1CCCC1 Show InChI InChI=1S/C19H24N4O/c1-13(14-6-8-16(9-7-14)23-10-2-3-11-23)19(24)20-18-12-17(21-22-18)15-4-5-15/h6-9,12-13,15H,2-5,10-11H2,1H3,(H2,20,21,22,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7148
(3-Benzamidoaminopyrazole deriv. 25 | 4-bromo-N-[5-...)Show InChI InChI=1S/C13H14BrN3O/c1-8(2)11-7-12(17-16-11)15-13(18)9-3-5-10(14)6-4-9/h3-8H,1-2H3,(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7126
(3-Propylaminopyrazole deriv. 3 | CHEMBL112442 | CS...)Show InChI InChI=1S/C10H15N3O/c1-2-3-10(14)11-9-6-8(12-13-9)7-4-5-7/h6-7H,2-5H2,1H3,(H2,11,12,13,14) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 224 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase/G2/mitotic-specific cyclin- 1
(Homo sapiens (Human)) | BDBM7108
((N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(2-naphthyl)a...)Show InChI InChI=1S/C18H17N3O/c22-18(19-17-11-16(20-21-17)14-7-8-14)10-12-5-6-13-3-1-2-4-15(13)9-12/h1-6,9,11,14H,7-8,10H2,(H2,19,20,21,22) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| DrugBank MMDB PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 270 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7127
(3-Benzamidoaminopyrazole deriv. 4 | CHEMBL324942 |...)Show InChI InChI=1S/C13H13N3O/c17-13(10-4-2-1-3-5-10)14-12-8-11(15-16-12)9-6-7-9/h1-5,8-9H,6-7H2,(H2,14,15,16,17) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL DrugBank MMDB PC cid PC sid PDB UniChem
Patents
Similars
| DrugBank MMDB PDB Article PubMed
| n/a | n/a | 290 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7136
(3-Benzamidoaminopyrazole deriv. 13 | CHEMBL333605 ...)Show InChI InChI=1S/C14H12F3N3O/c15-14(16,17)10-3-1-2-9(6-10)13(21)18-12-7-11(19-20-12)8-4-5-8/h1-3,6-8H,4-5H2,(H2,18,19,20,21) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7135
(3-Benzamidoaminopyrazole deriv. 12 | CHEMBL420135 ...)Show InChI InChI=1S/C14H15N3O2/c1-19-11-4-2-3-10(7-11)14(18)15-13-8-12(16-17-13)9-5-6-9/h2-4,7-9H,5-6H2,1H3,(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7146
(3-Benzamidoaminopyrazole deriv. 23 | 4-bromo-N-(5-...)Show InChI InChI=1S/C12H12BrN3O/c1-2-10-7-11(16-15-10)14-12(17)8-3-5-9(13)6-4-8/h3-7H,2H2,1H3,(H2,14,15,16,17) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 630 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7147
(3-Benzamidoaminopyrazole deriv. 24 | 4-bromo-N-(5-...)Show InChI InChI=1S/C13H14BrN3O/c1-2-3-11-8-12(17-16-11)15-13(18)9-4-6-10(14)7-5-9/h4-8H,2-3H2,1H3,(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 650 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7130
(3-Benzamidoaminopyrazole deriv. 7 | CHEMBL111897 |...)Show InChI InChI=1S/C14H15N3O2/c1-19-11-6-4-10(5-7-11)14(18)15-13-8-12(16-17-13)9-2-3-9/h4-9H,2-3H2,1H3,(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 705 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133573
(CHEMBL119530 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C17H13Cl2N3O2S/c18-13-7-4-8-14(19)12(13)9-16-20-15(10-25-16)21-17(23)22-24-11-5-2-1-3-6-11/h1-8,10H,9H2,(H2,21,22,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7133
(3-Benzamidoaminopyrazole deriv. 10 | 3-bromo-N-(5-...)Show InChI InChI=1S/C13H12BrN3O/c14-10-3-1-2-9(6-10)13(18)15-12-7-11(16-17-12)8-4-5-8/h1-3,6-8H,4-5H2,(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 990 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7134
(3-Benzamidoaminopyrazole deriv. 11 | 3-chloro-N-(5...)Show InChI InChI=1S/C13H12ClN3O/c14-10-3-1-2-9(6-10)13(18)15-12-7-11(16-17-12)8-4-5-8/h1-3,6-8H,4-5H2,(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7144
(3-Benzamidoaminopyrazole deriv. 21 | 4-bromo-N-(5-...)Show InChI InChI=1S/C16H18BrN3O/c17-13-8-6-12(7-9-13)16(21)18-15-10-14(19-20-15)11-4-2-1-3-5-11/h6-11H,1-5H2,(H2,18,19,20,21) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7138
(2-chloro-N-(5-cyclopropyl-1H-pyrazol-3-yl)benzamid...)Show InChI InChI=1S/C13H12ClN3O/c14-10-4-2-1-3-9(10)13(18)15-12-7-11(16-17-12)8-5-6-8/h1-4,7-8H,5-6H2,(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133557
(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-morphol...)Show InChI InChI=1S/C15H16Cl2N4O2S/c16-11-2-1-3-12(17)10(11)8-14-18-13(9-24-14)19-15(22)20-21-4-6-23-7-5-21/h1-3,9H,4-8H2,(H2,19,20,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133579
(CHEMBL117950 | N-(tert-butoxy)-N'-[2-(2,6-dichloro...)Show InChI InChI=1S/C15H17Cl2N3O2S/c1-15(2,3)22-20-14(21)19-12-8-23-13(18-12)7-9-10(16)5-4-6-11(9)17/h4-6,8H,7H2,1-3H3,(H2,19,20,21) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7137
(2-bromo-N-(5-cyclopropyl-1H-pyrazol-3-yl)benzamide...)Show InChI InChI=1S/C13H12BrN3O/c14-10-4-2-1-3-9(10)13(18)15-12-7-11(16-17-12)8-5-6-8/h1-4,7-8H,5-6H2,(H2,15,16,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7124
(3-Benzamidoaminopyrazole deriv. 1 | CHEMBL115125 |...)Show InChI InChI=1S/C11H11N3O/c1-8-7-10(14-13-8)12-11(15)9-5-3-2-4-6-9/h2-7H,1H3,(H2,12,13,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | 7.4 | 22 |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133564
(1-[2-(2,6-Dichloro-benzyl)-thiazol-4-yl]-3-pyrroli...)Show InChI InChI=1S/C15H16Cl2N4OS/c16-11-4-3-5-12(17)10(11)8-14-18-13(9-23-14)19-15(22)20-21-6-1-2-7-21/h3-5,9H,1-2,6-8H2,(H2,19,20,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133575
(CHEMBL119041 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C16H17Cl2N3O3S/c17-11-4-3-5-12(18)10(11)8-14-19-13(9-25-14)20-16(22)21-24-15-6-1-2-7-23-15/h3-5,9,15H,1-2,6-8H2,(H2,20,21,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133551
(CHEMBL119143 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C13H14Cl2N4OS/c1-19(2)18-13(20)17-11-7-21-12(16-11)6-8-9(14)4-3-5-10(8)15/h3-5,7H,6H2,1-2H3,(H2,17,18,20) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50133580
(CHEMBL119796 | N-[2-(2,6-dichlorobenzyl)-1,3-thiaz...)Show InChI InChI=1S/C13H13Cl2N3O2S/c1-2-20-18-13(19)17-11-7-21-12(16-11)6-8-9(14)4-3-5-10(8)15/h3-5,7H,2,6H2,1H3,(H2,17,18,19) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit Cyclin-dependent kinase 5-p35. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133569
(1-Morpholin-4-yl-3-[2-(pyridine-2-sulfonylmethyl)-...)Show InChI InChI=1S/C14H17N5O4S2/c20-14(18-19-5-7-23-8-6-19)17-11-9-24-12(16-11)10-25(21,22)13-3-1-2-4-15-13/h1-4,9H,5-8,10H2,(H2,17,18,20) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |
Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM7145
(3-Benzamidoaminopyrazole deriv. 22 | 4-bromo-N-(5-...)Show InChI InChI=1S/C11H10BrN3O/c1-7-6-10(15-14-7)13-11(16)8-2-4-9(12)5-3-8/h2-6H,1H3,(H2,13,14,15,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Italia
| Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates in the presence ATP/[gamma-33P] ATP. After in... |
J Med Chem 47: 3367-80 (2004)
Article DOI: 10.1021/jm031145u BindingDB Entry DOI: 10.7270/Q2RX998G |
More data for this Ligand-Target Pair | |
Cyclin-A1/Cyclin-A2/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM50133556
(1-Morpholin-4-yl-3-(2-phenyl-thiazol-4-yl)-urea | ...)Show InChI InChI=1S/C14H16N4O2S/c19-14(17-18-6-8-20-9-7-18)16-12-10-21-13(15-12)11-4-2-1-3-5-11/h1-5,10H,6-9H2,(H2,16,17,19) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pharmacia Corporation
Curated by ChEMBL
| Assay Description Ability to inhibit cyclin-dependent kinase 2-cyclin A. |
Bioorg Med Chem Lett 13: 3491-5 (2003)
BindingDB Entry DOI: 10.7270/Q2XG9QHN |
More data for this Ligand-Target Pair | |